Discussion about this post

User's avatar
The Stock Market Curator ๐Ÿ““'s avatar

Biotech names like VRCA and QNCX are bound to ignore the indexes, especially when they have their own catalyst, good or bad. For them, it's not so much about what the indexes are doing. Any news from the FDA can certainly send them on a wild swing. The systematic process is important, I agree.

No posts

Ready for more?